ID: ALA111858

Max Phase: Preclinical

Molecular Formula: C5H15N2O2P

Molecular Weight: 166.16

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCCCP(=O)(O)CCN

Standard InChI:  InChI=1S/C5H15N2O2P/c6-2-1-4-10(8,9)5-3-7/h1-7H2,(H,8,9)

Standard InChI Key:  BYVZTECKEWPHLD-UHFFFAOYSA-N

Associated Targets(non-human)

GABA-B receptor 1 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 166.16Molecular Weight (Monoisotopic): 166.0871AlogP: -0.44#Rotatable Bonds: 5
Polar Surface Area: 89.34Molecular Species: ZWITTERIONHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.61CX Basic pKa: 10.57CX LogP: -3.59CX LogD: -5.69
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.48Np Likeness Score: 0.71

References

1. Froestl W, Mickel SJ, von Sprecher G, Diel PJ, Hall RG, Maier L, Strub D, Melillo V, Baumann PA, Bernasconi R..  (1995)  Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.,  38  (17): [PMID:7650685] [10.1021/jm00017a016]

Source